Write a reviewFor vendors
♡
Home / Investors / Robert Adelman

Robert Adelman

Venture Fund · San Francisco

About Robert Adelman

Venture capital investor (Managing Partner) based in San Francisco, California. Focus areas include Patient Care, Health Care, Drug Discovery. Invests at series b stage. Past investments include Attralus, Aurinia Pharmaceuticals, Labrys Biologics.

Investment focus

Stages
Series B
Sectors
Patient CareHealth CareDrug DiscoveryAutoimmune DiseasesWellnessWomen FoundedLife ScienceMedical TechnologiesManufacturingBiotechnologyDrug DevelopmentClinical TrialsVaccinesMedicalB2BTherapeuticsPharmaceuticalsRisk Management

Portfolio

No portfolio companies recorded yet; Robert Adelman reports 38 investments overall.

Similar investors

Aakash Tulsani

Venture Fund · Singapore
Series BHealth CareHospitalsE-commerceSports+16
60Investments
—Exits

Aaref Hilaly

Angel Investor · San Francisco
SeedSeries BEarly Stage VentureSeries AHealth CareData IntegrationTalent ManagementE-commerce+16
60Investments
—Exits

Aaron Goldman

Venture Fund · New York City
Series BHealth CareTalent ManagementE-commerceWellness+16
60Investments
—Exits

Adam Goulburn

Venture Fund · New York City
Series BHealth CareRegenerative MedicineDrug DiscoveryData Science+16
60Investments
—Exits

Adam Greene

Venture Fund · New York City
Series BHealth CareArtificial Intelligence (AI)Information ServicesInformation Technology (IT)+14
60Investments
—Exits

Adam Margolin

Venture Fund · Boston
Series BAdvertisingHealth CareWearablesE-commerce+16
60Investments
—Exits